http://www.pmprb-cepmb.gc.ca/english/View.asp?x=508&mp=254

IN THE MATTER OF the Patent Act R.S.C. 1985, c. P-4,
as amended
IN THE MATTER OF Shire BioChem Inc.
(the “Respondent”) and the medicine “Adderall XR”


NOTICE OF HEARING

TAKE NOTICE that the Patented Medicine Prices Review Board (the “Board”) will hold a hearing at its offices in the Standard Life Centre, 333 Laurier Avenue West, 18th Floor, Ottawa, Ontario, commencing on April 24, 2006 at 9:30 a.m., or as soon thereafter as the hearing may be held. A pre-hearing conference has also been scheduled for March 8, 2006, at the Board's offices, starting at 9:30 a.m.

A. Purpose of the Hearing

1. The purpose of the hearing is to determine whether, under sections 83 and 85 of the Patent Act (the “Act”), the Respondent is selling or has sold the medicine known as Adderall XR in any market in Canada at prices that, in the Board´s opinion, are or were excessive and if so, what order, if any, should be made.

<SNIP>

<SNIP><FOR above Weblink on click article, of rest>